How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on: December 01,2024 0

How colliding genetic processes drive aggressive cancers

byUniversity of Chicago Medical CenterLoss of CDK12 promotes large TD formation. Credit:Nature Cancer(2024). DOI: 10.1038/s43018-024-00848-4Cancer researchers at the University of Ch

Updated on:December 01,2024 0

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of

Updated on: November 08,2024 0

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children's liver cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of

Updated on:November 08,2024 0

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w

Updated on: December 01,2024 0

Salmonella research unlocks the potential of bacteria to treat bowel cancer

byUniversity of GlasgowTILs from mice treated with Salmonella are functionally defective. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-024-00159-2Fighting bowel cancer w

Updated on:December 01,2024 0

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on: November 09,2024 0

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on:November 09,2024 0

Drug improves effectiveness of radiation for lung cancer that has spread to the brain

by Tim Tedeschi,University of CincinnatiActivation of GABA(A) receptors triggers cell depolarization and death. Credit:Cancers(2024). DOI: 10.3390/cancers16183167In new research, a t

Updated on: November 09,2024 0

Drug improves effectiveness of radiation for lung cancer that has spread to the brain

by Tim Tedeschi,University of CincinnatiActivation of GABA(A) receptors triggers cell depolarization and death. Credit:Cancers(2024). DOI: 10.3390/cancers16183167In new research, a t

Updated on:November 09,2024 0

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on: September 07,2024 0

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on:September 07,2024 0

An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne

Updated on: September 07,2024 0

An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne

Updated on:September 07,2024 0

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024 0

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024 0

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on: November 09,2024 0

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on:November 09,2024 0

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o

Updated on: November 30,2024 0

Immunotherapy shows potential to treat deadly thyroid cancer

by Olivia Dimmer,Northwestern UniversityCredit: Pixabay/CC0 Public DomainA type of immunotherapy appears to be effective in treating a deadly subset of thyroid cancer, according to the results o

Updated on:November 30,2024 0

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on: November 30,2024 0

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Updated on:November 30,2024 0

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Updated on: October 21,2024 0

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Updated on:October 21,2024 0